In January, Markus Schmidt, CEO/Founder of BioFaction, shared with us his most recent work on Biosafety in synthetic biology. Markus has an interdisciplinary background in biomedical engineering, biology and technology assessment and is currently involved in numerous projects that bring together science regulation, responsible research, innovation and art.